SELLAS Life Sciences Reports Second Quarter 2021 Financial
Reported Promising Updated Clinical Data in Ongoing Clinical Trials of Galinpepimut-S (GPS) in Combination with PD-1 Inhibitors for Malignant Pleural...
United States Angelos Stergiou Life Sciences Group Inc European Union Reported Promising Updated Clinical Data Ongoing Clinical Trials
Source: globenewswire.com